Phase I Study of OriC902 in Treatment of Advanced HCC
Phase I Study of OriC902 in Treatment of Advanced HCC
Recruiting · NCT06891742 · Registry updated 2025-03-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of OriC902 in Treatment of Advanced HCC | hepatocellular carcinoma | Recruiting | Phase 1 | 2025-03-24 | NCT06891742 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| OriCell Therapeutics Co., Ltd. | 5 |
| Peking University | 124 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Gobroad Hospital | Beijing | China | 3 |
| Peking University Cancer Hospital & Institute | Beijing | China | 5 |